Form 4: Axogen Executive Jens Kemp Reports Stock Transactions
SEC Form 4 Filing
Jens Kemp, Chief Marketing Officer of Axogen, Inc., reports the acquisition and disposal of company stock related to performance stock units and tax obligations.
Summary
- On February 22, 2025, Jens Kemp acquired 2,500 shares of Axogen common stock upon the attainment of certain performance criteria.
- On February 25, 2025, Kemp disposed of 814 shares to cover tax withholding obligations related to the vesting of performance stock units at a weighted average price of $16.49.
- Following these transactions, Kemp directly owns 1,686 shares of Axogen common stock.
Sentiment
Score: 5
Explanation: The document reflects standard executive stock transactions, indicating a neutral sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 02/22/2025 | Acquisition of 2,500 shares of common stock due to performance criteria attainment. |
| 02/24/2025 | Deemed execution date for the acquisition of shares. |
| 02/25/2025 | Sale of 814 shares to cover tax withholding obligations. |
| 02/26/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.